GlassScriptPhysician profile
Rodney T Steff
NPI 1013361526
$7,484.23
in general payments reported to CMS, 2019-2025
36 companies · $753 in 2025
The $753 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $72.99 · 2021: $198 · 2022: $629 · 2023: $5,232 · 2024: $471 · 2025: $753.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $1,892 · Travel and Lodging: $1,563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $1,892.05 |
| Travel and Lodging | $1,563.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,627.16 | 2023-2024 | Da Vinci Surgical System |
| Insmed, INC. | $285.62 | 2023-2025 | Arikayce, Brinsupri |
| Pulmonx Corporation | $279.87 | 2020-2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $225.82 | 2021-2025 | Ofev, Jascayd |
| Glaxosmithkline, LLC. | $220.00 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Baxter Healthcare | $153.58 | 2022-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Astrazeneca Pharmaceuticals LP | $149.15 | 2019-2025 | Fasenra, Breztri |
| Mylan Specialty L.P. | $148.14 | 2020-2024 | Yupelri |
| Genzyme Corporation | $121.82 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $104.61 | 2021-2024 | Dupixent |
| Abbvie INC. | $99.24 | 2021-2023 | Avycaz |
| Grifols USA, LLC | $95.26 | 2019-2023 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $90.21 | 2022-2024 | Zerbaxa, Recarbrio, Dificid |
| Boston Scientific Corporation | $85.33 | 2023-2025 | Cds - Mct/Cem Monitoring, Exalt Model D, Bodyguardian |
| Mallinckrodt Hospital Products INC. | $82.53 | 2022-2025 | Acthar |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $73.45 | 2023-2024 | Opsumit, Uptravi |
| Pfizer INC. | $59.60 | 2024-2025 | |
| Electromed, INC. | $55.78 | 2022-2023 | Smartvest |
| Stryker Corporation | $48.88 | 2025 | Flowtriever |
| Janssen Pharmaceuticals, INC | $45.34 | 2022 | |
| Mayne Pharma Commercial LLC | $43.48 | 2019 | |
| Jazz Pharmaceuticals INC. | $41.51 | 2022-2025 | |
| Abiomed | $40.60 | 2024-2025 | Impella |
| Teva Pharmaceuticals USA, INC. | $37.67 | 2021-2022 | |
| La Jolla Pharmaceutical Company | $37.07 | 2021-2024 | Giapreza |
| Ani Pharmaceuticals, INC. | $31.51 | 2025 | Purified Cortrophin Gel |
| Amgen INC. | $29.11 | 2019-2022 | |
| Abbott Laboratories | $22.33 | 2022 | |
| Atricure, INC. | $21.88 | 2022 | |
| Ambu INC. | $21.73 | 2022 | |
| Zoll Circulation INC | $18.91 | 2025 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| Alnylam Pharmaceuticals INC. | $18.38 | 2021 | |
| Advanced Respiratory, INC | $18.14 | 2020 | |
| Livanova USA, INC. | $17.63 | 2022 | |
| Allergan, INC. | $17.25 | 2020 | |
| Fisher & Paykel Healthcare INC | $15.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Steff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.